Freya Biosciences
Freya is a clinical-stage firm that is adopting a novel approach to women's health. With microbial immunotherapies designed to alleviate the chronic inflammation at the root of a variety of reproductive system disorders that specifically affect women.
Total Fundraised$49.4M
2023
Copenhagen, Denmark
-
Series A
https://freyabiosciences.com/Freya Biosciences's Stages
Series A
Funding Types by Funds Raised (in USD)
Content Locked
Login or Register a FREE account to continue browsing our content
Cumulative Funding Raised Over Time
Content Locked
Login or Register a FREE account to continue browsing our content
Freya Biosciences's Investors by Funding Rounds
| Funding Round | Announced Date | Disclosed Investors | Round Amount (USD) |
|---|---|---|---|
Series A | 12 Dec 2023 | Crescent Enterprises Venture Capital Sofinnova Partners OMX Ventures The Export and Investment Fund of Denmark Angelini Ventures Mike Jafar Family Office Corundum Systems Biology Indaco Venture Partners | 38M 8 Investors |
Series A | 19 Nov 2024 | Bill & Melinda Gates Foundation The Export and Investment Fund of Denmark | 11.4M 2 Investors |
Content Locked
Login or Register a FREE account to continue browsing our content
%2Fuploads%2Fpr%2520articles%2F2024%2F02%2F01_1CE-V.jpg&w=3840&q=75)
